Colon Carcinoma Metastases clinical trials

Explore recruiting colon carcinoma metastases clinical trials.

Recruiting colon carcinoma metastases studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colon Carcinoma Metastases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double-blind, randomized, placebo-controlled, study to evaluate the safety and efficacy of HRX215 in participants after major hepatectomy, preceded by two open pilot parts in participants after minor and after major hepatectomy due to colon carcinoma metastases

France, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Colon Carcinoma Metastases trials by city

Colon Carcinoma Metastases clinical trials

Recruiting colon carcinoma metastases studies right now

AB122 Platform Study

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases

Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Also recruiting in Europe

Double-blind, randomized, placebo-controlled, study to evaluate the safety and efficacy of HRX215 in participants after major hepatectomy, preceded by two open pilot parts in participants after minor and after major hepatectomy due to colon carcinoma metastases

Colon Carcinoma Metastases trials by city

Other conditions